SCHEMBL15536766

SCHEMBL15536766

CC(C)OC(=O)c1cccc(NC(=O)C=Cc2c[nH]c3ccccc23)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.54
▸ NPC1 O15118 7/20 0.54
▸ RAB9A P51151 7/20 0.54
▸ SMN1; SMN2 Q16637 7/20 0.54
▸ HTT P42858 1/20 0.54
▸ JAK3 P52333 1/20 0.51
▸ IMPDH2 P12268 1/20 0.50
▸ MEN1 O00255 8/20 0.49
▸ KMT2A Q03164 8/20 0.49
▸ POLB P06746 1/20 0.49
▸ ALDH1A1 P00352 7/20 0.49
▸ HPGD P15428 3/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ NFKB2 Q00653 1/20 0.49
▸ RELA Q04206 1/20 0.49
▸ LMNA P02545 5/20 0.47
▸ KDM4E B2RXH2 3/20 0.46
▸ GAA P10253 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2084371 0.90 IMPDH2 (0.55) MAPTNPC1RAB9ASMN1; SMN2JAK3
SCHEMBL2084374 0.90 IMPDH2 (0.55) MAPTNPC1RAB9ASMN1; SMN2JAK3
SCHEMBL16790671 0.86 MEN1 (0.60) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL15537939 0.84 BACE1 (0.48) MAPTNPC1RAB9ASMN1; SMN2JAK3
SCHEMBL2086187 0.84 MEN1 (0.62) MAPTNPC1RAB9ASMN1; SMN2JAK3
SCHEMBL2086185 0.84 MEN1 (0.62) MAPTNPC1RAB9ASMN1; SMN2JAK3
SCHEMBL15538768 0.83 MEN1 (0.58) MAPTNPC1RAB9ASMN1; SMN2JAK3
SCHEMBL29678247 0.83 PARP1 (0.58) MAPTNPC1RAB9ASMN1; SMN2JAK3
SCHEMBL18929474 0.83 MEN1 (0.55) MAPTNPC1RAB9ASMN1; SMN2JAK3
SCHEMBL2085438 0.83 PARP1 (0.58) MAPTNPC1RAB9ASMN1; SMN2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10301598-B2 Low-molecular-compound for improving production, maintenance and proliferation of pluripotent stem cells, composition comprising the same, and culture method KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2019-05-28 — — US disclosed
US-20170159023-A1 NOVEL LOW-MOLECULAR-COMPOUND FOR IMPROVING PRODUCTION, MAINTENANCE AND PROLIFERATION OF PLURIPOTENT STEM CELLS, COMPOSITION COMPRISING THE SAME, AND CULTURE METHOD KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2017-06-08 — — US disclosed
EP-2774918-B1 NOVEL LOW-MOLECULAR WEIGHT COMPOUND FOR PROMOTING PLURIPOTENT STEM CELL GENERATION, MAINTENANCE, AND PROLIFERATION, AND COMPOSITION AND CULTURING METHOD CONTAINING SAME KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR) 2017-03-22 — — EP disclosed
US-9587225-B2 Low-molecular-compound for improving production, maintenance and proliferation of pluripotent stem cells, composition comprising the same, and culture method KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2017-03-07 — — US disclosed
US-20150159142-A1 NOVEL LOW-MOLECULAR-COMPOUND FOR IMPROVING PRODUCTION, MAINTENANCE AND PROLIFERATION OF PLURIPOTENT STEM CELLS, COMPOSITION COMPRISING THE SAME, AND CULTURE METHOD Korea Reasearch Institute of Bioscience and Biotechnology (KR) 2015-06-11 — — US disclosed
EP-2774918-A1 NOVEL LOW-MOLECULE COMPOUND FOR PROMOTING PLURIPOTENT STEM CELL GENERATION, MAINTENANCE, AND PROLIFERATION, AND COMPOSITION AND CULTURING METHOD CONTAINING SAME Korea Research Institute of Bioscience and Biotechology (KR) 2014-09-10 — — EP disclosed
WO-2013180350-A1 NOVEL LOW-MOLECULE COMPOUND FOR PROMOTING PLURIPOTENT STEM CELL GENERATION, MAINTENANCE, AND PROLIFERATION, AND COMPOSITION AND CULTURING METHOD CONTAINING SAME 한국생명공학연구원 (KR) 2013-12-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150159142-A1 NOVEL LOW-MOLECULAR-COMPOUND FOR IMPROVING PRODUCTION, MAINTENANCE AND PROLIFERATION OF PLURIPOTENT STEM CELLS, COMPOSITION COMPRISING THE SAME, AND CULTURE METHOD MYC, MYCBP, HES1 MAPT 3105/4885NPC1 4780/4885RAB9A 4062/4885
US-10301598-B2 Low-molecular-compound for improving production, maintenance and proliferation of pluripotent stem cells, composition comprising the same, and culture method AANAT, MKI67, VIM MAPT 2405/4885NPC1 4608/4885RAB9A 4645/4885
US-20170159023-A1 NOVEL LOW-MOLECULAR-COMPOUND FOR IMPROVING PRODUCTION, MAINTENANCE AND PROLIFERATION OF PLURIPOTENT STEM CELLS, COMPOSITION COMPRISING THE SAME, AND CULTURE METHOD AANAT, MKI67, ACP1 MAPT 3253/4885NPC1 4664/4885RAB9A 4684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback